Dr Phil Jennings, Chief Officer of Health Innovation North West Coast and Health Innovation Network Lead for the Rapid Uptake Products, explains the new treatment inclisiran in this video for GPs and healthcare professionals.*
*Created to inform healthcare professionals only, to support them to roll-out the treatment.
During 2021, NICE recommended two novel therapies for patients with elevated cholesterol as part of the lipids management pathway: bempedoic acid and inclisiran. An overview of the collaboration between NHS England and Novartis Pharmaceuticals for the addition of inclisiran to the lipids management pathway is available on the AAC’s webpage.
In this podcast Dr Phil Jennings explores the science behind Inclisiran and the evidence of its effectiveness. His guests are Professor Kausik Ray, Professor of Public Health, Honorary Consultant Cardiologist and Director of Imperial Centre for Cardiovascular Disease Prevention at Imperial College London; and to Dr Carl Deaney, a GP in Lincolnshire.